• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    DIH Announces Third Quarter 2025 Financial Results

    2/14/25 5:07:01 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email

    NORWELL, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the third fiscal quarter ended December 31, 2024.

    Recent Highlights

    • Revenue of $15.1 million for the quarter ended December 31, 2024, representing a decline of 21% over the prior year period
    • Device revenue of $11.7 million and service revenue of $3.1 million for the quarter ended December 31, 2024, representing a decline of 26% and growth of 4%, respectively, over the prior year period
    • Revenue decline in Europe, Middle East and Africa (EMEA) and the Americas of 29% and 7%, respectively, over the prior year period
    • Announced collaborations with Nobis Rehabilitation Partners and Zahrawi Group, expanding our distribution network and device integration pipeline
    • Closed on a public offering yielding gross proceeds of approximately $4.6 million before deducting placement agent's fees other offering expenses
    • Reiterated revenue guidance for the fiscal year 2025 to range between $60 and $67 million

    "Our third quarter results were in line with our expectations despite facing challenges with import restrictions related to the ongoing conflict between Russia and Ukraine and lower overall European sales volumes. We continue to position the company for future success through upgrades to our commercial organizations while also remaining focused on reaching our year-end revenue targets," said Jason Chen, Chairman and CEO of DIH. "Interest in our products remains high, as evidenced by multiple recently formed partnerships, and the recent stock offering will enable us to continue working towards fulfilling this order demand. We remain confident for a strong finish through the remainder of fiscal year 2025 and are reiterating our full year revenue guidance range of $60 to $67 million."

    Financial Results for the Third Fiscal Quarter Ended December 31, 2024

    Revenue for the three months ended December 31, 2024 decreased by $3.9 million, or 20.6%, to $15.1 million from $19.0 million for the three months ended December 31, 2023. The overall decrease was primarily due to a decrease in devices sold of $4.0 million, or 25.6% year over year. The decrease in devices revenue was primarily driven by lower sales volume in EMEA. In EMEA, we sell our equipment through a distributor network across Europe. One of our largest sales partners, which primarily operates in Eastern Europe, has been impacted by wartime import restrictions resulting from the ongoing conflict between Russia and Ukraine. The decrease was offset by a $0.1 million increase in service revenue for the three months ended December 31, 2024 compared to the three months ended December 31, 2023. Other revenue was consistent in the three months ended December 31, 2024 compared to that in the three months ended December 31, 2023. Total revenue in the EMEA and in the Americas decreased by $3.6 million and $0.3 million, respectively, to $8.7 million and $3.5 million for the three months ended December 31, 2024 compared to $12.3 million and $3.8 million for the three months ended December 31, 2023.

    The impact due to foreign currency translation gain was $0.2 million for the three months ended December 31, 2024.

    Gross profit for the third fiscal quarter ended December 31, 2024, was $7.2 million, a decrease of 30.4% compared to the prior year period. The decrease was driven by a decrease in sales of $3.9 million, primarily in the EMEA region. Cost of sales for the three months ended December 31, 2024 decreased by $0.8 million, or 8.7%, to $7.9 million from $8.6 million for the three months ended December 31, 2023.

    Selling, general and administrative expense for the three months ended December 31, 2024 increased by $2.8 million, or 50.6%, to $8.2 million from $5.4 million for the three months ended December 31, 2023. The increase was driven by a $1.1 million increase in employee compensation due to increase in headcount and stock compensation and $1.0 million increase in other overhead costs to support future sales growth. The increase is also attributable to $0.5 million increase in professional service costs in connection with the Company becoming a publicly listed company during the year.

    Research and development costs for the three months ended December 31, 2024 increased by $0.1 million, or 7.7%, to $1.8 million from $1.7 million for the three months ended December 31, 2023. The increase was primarily attributable to a $0.2 million increase in the amortization expense related to capitalized software that was ready for its intended use in July 2024. The increase was offset by a $0.1 million decrease in external consulting fees.

    Cash and cash equivalents on December 31, 2024 totaled $1.1 million.

    Fiscal Year 2025 Outlook

    The Company has reiterated its revenue guidance for fiscal year 2025 to range between $60 million and $67 million.

    Subsequent Events

    On February 3, 2025, the Company closed an offering of 5,937,100 Units ("Units"), each consisting of one share of common stock, par value $0.0001 per share, and one Class A warrant to purchase one share of common stock at a public offering price of $0.7832 per Unit, for gross proceeds of $4.6 million. The Units have no stand-alone rights and will not be certified or issued as stand-alone securities. The common stock and Class A warrants are immediately separable and were issued separately in this offering. Each Class A warrant was immediately exercisable for one share of common stock at an exercise price of $0.7832 per share (100% of the public offering price per Unit) and will expire on the fifth anniversary of the original issuance date. The offering resulted in a net proceeds of approximately $3.9 million, after deducting placement agent fees sand estimated offering expenses payable by the Company.

    Subsequent to the close of the stock offering, the conversion price of the Debentures and the exercise price of the warrants issued in connection with the convertible note changed to $0.7832 pursuant to the Purchase Agreement. The number of Common Stock issuable increased to 2,106,742 shares from 330,000 shares.

    About DIH Holding US, Inc.

    DIH stands for the vision to "Deliver Inspiration & Health" to improve the daily lives of millions of people with disabilities and functional impairments through providing devices and solutions enabling intensive rehabilitation. DIH is a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Built through the mergers of global-leading niche technology providers, DIH is a transformative rehabilitation solutions provider and consolidator of a largely fragmented and manual-labor-driven industry.

    Caution Regarding Forward-Looking Statement

    This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the business combination, the services offered by DIH and the markets in which it operates, and DIH's projected future results. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the ability of DIH to achieve its projected revenue, the failure of DIH realize the anticipated benefits of the recently-completed business combination and access to sources of additional debt or equity capital if needed. While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.

    Investor Contact

    Greg Chodaczek

    [email protected]



    DIH HOLDING US, INC.

    CONSOLIDATED BALANCE SHEETS

    (in thousands, except share and per share data, unaudited)



      As of December

    31, 2024
      As of March 31,

    2024
     
    Assets      
    Current assets:      
    Cash and cash equivalents $1,120  $3,225 
    Accounts receivable, net of allowances of $240 and $667, respectively  3,834   5,197 
    Inventories, net  7,962   7,830 
    Due from related party  6,333   5,688 
    Other current assets  4,909   5,116 
    Total current assets  24,158   27,056 
    Property, and equipment, net  714   530 
    Capitalized software, net  1,768   2,131 
    Other intangible assets, net  380   380 
    Operating lease, right-of-use assets, net  3,735   4,466 
    Other tax assets  152   267 
    Other assets  907   905 
    Total assets $31,814  $35,735 
    Liabilities and Deficit      
    Current liabilities:      
    Accounts payable $3,945  $4,305 
    Due to related party  10,213   10,192 
    Advance payments from customers  9,476   10,562 
    Current portion of deferred revenue  6,644   5,211 
    Employee compensation  3,937   2,664 
    Current maturities of convertible debt, at fair value  1,918   — 
    Current portion of long-term operating lease  1,331   1,572 
    Manufacturing warranty obligation  582   513 
    Accrued expenses and other current liabilities ($1,111 measured at fair value)  9,278   9,935 
    Total current liabilities  47,324   44,954 
    Notes payable - related party  8,648   11,457 
    Non-current deferred revenues  4,986   4,670 
    Long-term operating lease  2,443   2,917 
    Convertible debt, net of current maturities, at fair value  693   — 
    Deferred tax liabilities  221   112 
    Other non-current liabilities  5,381   4,171 
    Total liabilities  69,696   68,281 
    Commitments and contingencies      
    Deficit:      
    Preferred stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2024 and March 31, 2024  —   — 
    Common stock, $0.0001 par value; 100,000,000 shares authorized; 34,861,837 shares issued and outstanding at December 31, 2024; 34,544,935 shares issued and outstanding at March 31, 2024  3   3 
    Additional paid-in-capital  3,773   2,613 
    Accumulated deficit  (39,484)  (35,212)
    Accumulated other comprehensive income (loss)  (2,174)  50 
    Total deficit  (37,882)  (32,546)
    Total liabilities and deficit $31,814  $35,735 





    DIH HOLDING US, INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (in thousands, except per share data, unaudited)



     Three Months Ended

    December 31,
      For the Nine Months Ended

    December 31,
     
      2024  2023  2024  2023 
    Revenue $15,094  $19,011  $50,216  $45,116 
    Cost of sales  7,858   8,611   23,968   23,911 
    Gross profit  7,236   10,400   26,248   21,205 
    Operating expenses:            
    Selling, general, and administrative expense  8,196   5,443   22,564   17,652 
    Research and development  1,786   1,659   5,341   4,681 
    Total operating expenses  9,982   7,102   27,905   22,333 
    Operating income (loss)  (2,746)  3,298   (1,657)  (1,128)
    Other income (expense):            
    Interest expense  (25)  (185)  (186)  (460)
    Other income (expense), net  (590)  237   (1,004)  (181)
    Total other income (expense)  (615)  52   (1,190)  (641)
    Income (loss) before income taxes  (3,361)  3,350   (2,847)  (1,769)
    Income tax expense  367   381   1,425   659 
    Net Income (loss) $(3,728) $2,969  $(4,272) $(2,428)
                 
    Net income (loss) per share, basic and diluted $(0.11) $0.12  $(0.12) $(0.10)
    Weighted average common shares outstanding, basic and diluted  34,645   25,000   34,578   25,000 





    DIH HOLDING US, INC.

    CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

    (in thousands, unaudited)



      Three Months Ended

    December 31,
      For the Nine Months Ended

    December 31,
     
      2025 2023  2024 2023 
    Net Income (loss) $(3,728) $2,969  $(4,272) $(2,428)
    Other comprehensive (loss) income, net of tax            
    Foreign currency translation adjustments, net of tax of $0  (145)  636   (1,079)  876 
    Pension liability adjustments, net of tax of $0  (64)  (704)  (1,145)  (1,064)
    Other comprehensive loss  (209)  (68)  (2,224)  (188)
    Comprehensive income (loss) $(3,937) $2,901  $(6,496) $(2,616)





    DIH HOLDING US, INC. AND SUBSIDIARIES

    CONDENSED COMBINED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

    (in thousands, unaudited)

     For the Three Months Ended December 31, 
     Common Stock         
     Shares Amount Additional

    Paid-In

    Capital
     Accumulated

    Deficit
     Accumulated

    Other

    Comprehensive

    Income (Loss)
     Total

    Equity

    (Deficit)
     
    Balance, September 30, 2024 34,544,935 $3 $3,323 $(35,756)$(1,965)$(34,395)
    Net loss —  —  —  (3,728) —  (3,728)
    Other comprehensive loss, net of tax —  —  —  —  (209) (209)
    Net transactions with parent 316,902  —  450  —  —  450 
    Balance, December 31, 2024 34,861,837 $3 $3,773 $(39,484)$(2,174)$(37,882)
                 
     Shares(1) Amount Additional

    Paid-In

    Capital
     Accumulated

    Deficit
     Accumulated

    Other

    Comprehensive

    Income (Loss)
     Total

    Equity

    (Deficit)
     
    Balance, September 30, 2023 25,000,000 $2 $(1,898)$(32,166)$(409)$(34,471)
    Net loss —  —  —  2,969  —  2,969 
    Other comprehensive loss, net of tax —  —  —  —  (68) (68)
    Balance, December 31, 2023 25,000,000 $2 $(1,898)$(29,197)$(477)$(31,570)
                 





     For the Nine Months Ended December 31, 
     Common Stock         
     Shares Amount Additional

    Paid-In

    Capital
     Accumulated

    Deficit
     Accumulated

    Other

    Comprehensive

    Income (Loss)
     Total

    Equity

    (Deficit)
     
    Balance, March 31, 2024 34,544,935 $3 $2,613 $(35,212)$50 $(32,546)
    Net loss —  —  —  (4,272) —  (4,272)
    Out of period adjustment related to reverse recapitalization (Note 2) —  —  710  —  —  710 
    Other comprehensive loss, net of tax —  —  —  —  (2,224) (2,224)
    Stock Compensation 316,902  —  450  —  —  450 
    Balance, December 31, 2024 34,861,837 $3 $3,773 $(39,484)$(2,174)$(37,882)
                 
     Shares(1) Amount Additional

    Paid-In

    Capital
     Accumulated

    Deficit
     Accumulated

    Other

    Comprehensive

    Income (Loss)
     Total

    Equity

    (Deficit)
     
    Balance, March 31, 2023 25,000,000 $2 $(1,898)$(26,769)$(289)$(28,954)
    Net loss —  —  —  (2,428) —  (2,428)
    Other comprehensive loss, net of tax —  —  —  —  (188) (188)
    Balance, December 31, 2023 25,000,000 $2 $(1,898)$(29,197)$(477)$(31,570)
                 

    (1) All outstanding share and per-share amounts have been restated to reflect the reverse recapitalization as established in the Business Combination Agreement as described in Note 1 to the condensed consolidated financial statements.



    DIH HOLDING US, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands, unaudited)
      For the Nine Months Ended December 31, 
      2024  2023 
    Cash flows from operating activities:      
    Net loss $(4,272) $(2,428)
    Adjustments to reconcile net loss to net cash provided by operating activities:      
    Depreciation and amortization  611   230 
    Provision for credit losses  (427)  (815)
    Allowance for inventory obsolescence  (67)  705 
    Stock compensation  450   — 
    Pension contributions  (475)  (456)
    Pension expense  238   201 
    Change in fair value of convertible debt and warrant liability  1,193   — 
    Foreign exchange (gain) loss  (241)  181 
    Noncash lease expense  1,263   1,165 
    Noncash interest expense  —   19 
    Deferred and other noncash income tax (income) expense  257   (237)
    Changes in operating assets and liabilities:      
    Accounts receivable  1,762   1,298 
    Inventories  (106)  (2,186)
    Due from related parties  (1,079)  (294)
    Due to related parties  100   1,910 
    Other assets  114   (2,540)
    Operating lease liabilities  (1,275)  (1,352)
    Accounts payable  (336)  1,484 
    Employee compensation  1,276   (603)
    Other liabilities  157   205 
    Deferred revenue  1,819   807 
    Manufacturing warranty obligation  75   189 
    Advance payments from customers  (1,036)  4,992 
    Accrued expense and other current liabilities  (849)  702 
    Net cash provided by (used in) operating activities  (848)  3,177 
    Cash flows from investing activities:      
    Purchases of property and equipment  (444)  (135)
    Net cash used in investing activities  (444)  (135)
    Cash flows from financing activities:      
    Proceeds from issuance of convertible debt, net of issuance costs  2,809   — 
    Payment on convertible debt  (471)  — 
    Payments on related party notes payable  (3,156)  (4,543)
    Net cash used in financing activities  (818)  (4,543)
    Effect of currency translation on cash and cash equivalents  5   5 
    Net decrease in cash, and cash equivalents, and restricted cash  (2,105)  (1,496)
    Cash, cash equivalents and restricted cash - beginning of period  3,225   3,175 
    Cash, cash equivalents and restricted cash- end of period $1,120  $1,679 
           
    Supplemental disclosure of cash flow information:      
    Interest paid $218  $442 
    Income tax paid $15  $— 
    Supplemental disclosure of non-cash investing and financing activity:      
    Accounts payable settled upon reverse recapitalization $710  $— 


    Primary Logo

    Get the next $DHAI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    SEC Filings

    See more
    • DIH Holdings US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - DIH HOLDING US, INC. (0001883788) (Filer)

      5/30/25 7:49:50 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by DIH Holdings US Inc.

      424B3 - DIH HOLDING US, INC. (0001883788) (Filer)

      5/12/25 5:00:16 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by DIH Holdings US Inc.

      424B3 - DIH HOLDING US, INC. (0001883788) (Filer)

      5/12/25 4:45:27 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    See more
    • DIH Appoints Shepherd Center as a DIH Center of Excellence

      NORWELL, Mass. and ATLANTA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Shepherd Center as DIH Center of Excellence. Through this partnership, DIH and Shepherd Center aim to further enhance rehabilitation outcomes and drive advancements in rehabilitation, creating new opportunities for patient recovery. The DIH Center of

      12/23/24 7:00:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Appoints Sheltering Arms Institute as a DIH Center of Excellence

      NORWELL, Mass. and RICHMOND, Va., Dec. 16, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the designation of Sheltering Arms Institute, a collaboration with VCU Health, as DIH Center of Excellence. By partnering with Sheltering Arms Institute, DIH continues to build a strong presence among top-tier healthcare providers dedicated to enhancing patient re

      12/16/24 4:05:00 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Appoints Dietmar Dold as Chief Operating Officer

      NORWELL, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced the appointment of Mr. Dietmar Dold as Chief Operating Officer, effective immediately.  Mr. Dold brings to DIH over 25 years of operating experience across multiple industries, and has demonstrated significant expertise in driving innovative transformation on a global scale. In his role as Chief Operating Officer, Mr. Dold will define and lead DIH's multi-group operating strategy, where he is expected to optimize manufacturing and sourcing initiatives, buil

      11/4/24 8:17:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

      SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

      11/14/24 6:07:49 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

      SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

      11/14/24 12:46:18 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D filed by DIH Holdings US Inc.

      SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

      2/20/24 5:18:47 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DIH Announces Third Quarter 2025 Financial Results

      NORWELL, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the third fiscal quarter ended December 31, 2024. Recent Highlights Revenue of $15.1 million for the quarter ended December 31, 2024, representing a decline of 21% over the prior year periodDevice revenue of $11.7 million and service reven

      2/14/25 5:07:01 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Expands Strategic Partnership with Zahrawi Group

      NORWELL, Mass. and DUBAI, United Arab Emirates, Feb. 04, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the expansion of their strategic partnership with Zahrawi Group (MTC Company), DIH's representative and sales partner, to include Saudi Arabia.  Building on a successful collaboration that started in 2019, the partnership now spans four countries: th

      2/4/25 8:00:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Announces Closing of $4.6 Million Public Offering

      NORWELL, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the closing of its previously announced public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit. Each unit consists of one share of Class A common stock and one Class A warrant to purchase one share of Class A common stock

      2/3/25 4:05:00 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Baucus Max was granted 52,817 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:26 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Director Chen Cathryn was granted 105,634 shares and acquired 4,885,173 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:23 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Director Eberts F Samuel Iii was granted 105,634 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:23 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care